AstraZeneca faces patent losses


AstraZeneca has been suffering through a string of patent losses, and new patent expirations are expected to bring more generic competition. AstraZeneca has faced generic challengers to Nexium, and Crestor and Seroquel XR are set to face generic challenges as the patents expire in the upcoming months.

Read the source article at Pharma News

About the Author

Related Posts

Leave a Reply